Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.
Manisha Bhutani, Mark N Polizzotto, Thomas S Uldrick...
https://pubmed.ncbi.nlm.nih.gov/25843728/Actively Recruiting
Led by National Cancer Institute (NCI) · Updated on 2026-11-03
150
Participants Needed
1
Research Sites
104 weeks
Total Duration
Kaposi sarcoma KS is a tumor caused by the Kaposi sarcoma herpesvirus, often affecting the skin but also appearing in lymph nodes, lungs, and the digestive tract. It is most common in people with weakened immune systems, such as those with HIV, but can also occur in otherwise healthy individuals. Researchers aim to better understand how KS develops, why it may recur, and how it impacts the immune system and organs over time. This observational study will follow adults aged 18 and older with histologically confirmed KS. Participants will undergo physical exams, blood tests, imaging scans, and may have biopsies of their tumors. Assessments will include eye exams, heart ultrasound, saliva and urine samples, skin and lymph node biopsies, swabs, photographs of lesions, and fluid samples from around organs as needed. These evaluations will be repeated six times over 18 months and then yearly for up to 10 years while participants continue their standard KS treatment. During the study, participants will visit the clinic regularly for comprehensive evaluations of their KS. Researchers will collect medical history, tissue samples, and participant-reported outcomes to study KS progression, remission, and recurrence by subtype. They will monitor immune status, disease patterns, and related inflammatory syndromes. The primary measure is characterizing the natural history of KS over 10 years, with ongoing safety monitoring and long-term follow-up continuing through the study period, which may last up to 12 years.
CONDITIONS
Natural History Study of Kaposi Sarcoma
I
Irene B Ekwede, R.N.
R
Ramya M Ramaswami, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Cancer Institute (NCI)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants undergo physical exams, blood tests, imaging scans, biopsies, and other assessments to monitor Kaposi sarcoma. These evaluations are done six times over the first 18 months and then yearly for up to 10 years. Participants continue their standard KS treatment throughout the study.
6 visits over 18 months, then yearly visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Manisha Bhutani, Mark N Polizzotto, Thomas S Uldrick...
https://pubmed.ncbi.nlm.nih.gov/25843728/Hilary A Robbins, Ruth M Pfeiffer, Meredith S Shiels...
https://pubmed.ncbi.nlm.nih.gov/25663691/Gianna Ballon, Gunkut Akar, Ethel Cesarman
https://pubmed.ncbi.nlm.nih.gov/25607954/National Cancer Institute (NCI)
Lead Sponsor